To determine the association among treatment outcomes and mechanical factors associated with CHJP.
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C
hronic hip joint pain (CHJP) is a major cause of hip dysfunction in the young to middle-aged adult, resulting in significant limitations in activity participation. 5, 7, 26 Chronic hip joint pain, often associated with diagnoses such as femoroacetabular impingement, developmental dysplasia of the hip, chondral lesions, and acetabular labral tears, commonly presents during the early, preradiographic stage of osteoarthritis. Without proper treatment, these conditions are believed to progress to hip osteoarthritis, 2, 15, 22, 28 a leading cause of reduced quality of life (QoL) and loss of function for older people. There is a clear need for effective treatment strategies to improve function and potentially to prevent or delay the onset of osteoarthritis in people with CHJP. DPT The goal of the current study was to determine the association among treatment outcomes and mechanical factors proposed to be associated with CHJP, including lower extremity movement patterns, hip abductor strength, and femoral head sphericity associated with cam-type femoroacetabular impingement. We therefore collected data from all patients who completed MPT, including those who completed MPT immediately after baseline testing and those who were initially randomized to the waitlist group, then allowed to participate in MPT after the initial study phase. 12 Based on our previous findings of MPT impact on patient-reported function and movement patterns, 12 we hypothesized that a reduction in hip adduction motion would be associated with an improvement in patient-reported outcomes (PROs). We also hypothesized that increased muscle strength after treatment and a smaller alpha angle, representing normal femoral head-neck sphericity, would be associated with an improvement in PROs.
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Study Design
T his study presents ancillary data to a feasibility RCT using a timecontrolled design.
12 FIGURE 1 provides an overview of the entire study design. Methods and results of the feasibility RCT, comparing those patients who received MPT to those randomized to a wait list, have been published previously. 12 After completion of their waiting period and postwait/pretreatment testing, patients initially randomized to the wait-list group participated in MPT. The data for all patients receiving MPT were pooled to perform the analysis in this study. These pooled data allowed additional analyses to investigate the mechanical factors associated with the treatment outcomes.
Participants
Potential participants included in this study were recruited between 2011 and 2013 from the community, using public announcements, Washington University School of Medicine's research volunteer database, and referrals from Washington University School of Medicine's clinical practice, including orthopaedic surgery, physical medicine and rehabilitation, and physical therapy. To be eligible, patients had to be 18 to 40 years of age and report that they had CHJP, defined as anterior groin or deep hip joint pain present for at least the past 3 months. Hip joint pain had to be reproducible with the flexion, adduction, internal rotation test. Exclusion criteria included: (1) body mass index (BMI) greater than 30 kg/m 2 to allow reliable kinematic testing, (2) prior hip fracture or surgery, (3) contraindications for magnetic resonance imaging (MRI), (4) pregnancy, (5) neurological involvement that impaired coordination or balance, and (6) low back or knee pain limiting the ability to perform functional tasks. Potential participants were also screened for differential diagnosis and excluded if screening results indicated lumbar spine radiculopathy. This study was approved by the Human Research Protection Office of Washington University School of Medicine, and all patients signed an informed-consent statement prior to participating in the study.
Pretreatment Assessment
After consent was obtained, the patients participated in pretreatment assessment that included completion of questionnaires to document demographic information and PROs to quantify hipspecific physical function and activity level. After a 5-minute warm-up using a stationary bike or treadmill, laboratory testing was completed that included 3-D kinematic assessment to quantify lower extremity motion and resistance tests, using handheld dynamometry, to quantify hip abductor strength. Magnetic resonance imaging was used to assess acetabular and femoral bony morphology.
Despite recent advances in the understanding of hip conditions that contribute to CHJP, there is still uncertainty regarding the best treatment approach, in part due to the limited available evidence, particularly for rehabilitation. 1, 3, 10, 24, 30 The preponderance of literature is focused on surgical interventions and is primarily observational. 10 There are no published randomized clinical trials (RCTs) to compare surgical to nonsurgical treatment outcomes. Despite this lack of evidence from high-quality studies, the number of surgical procedures to treat CHJP has grown exponentially. 4, 23 Although rehabilitation provides a relatively inexpensive alternative to surgery, additional studies are needed to establish its effectiveness and better understand the mechanical factors associated with treatment outcomes.
Movement-pattern training (MPT) is a rehabilitation approach with the goal of reducing stresses on the hip joint by optimizing lower extremity and hip biomechanics during functional tasks. 12 Movement-pattern training, as applied in this study, incorporates 2 primary components: (1) to provide each person with task-specific training to correct impaired movement patterns during daily and patient-specific tasks, in particular, the pattern of excessive hip adduction motion; and (2) to strengthen weak hip musculature thought to contribute to the impaired movement patterns. In a previous feasibility RCT using MPT, 12 patients with CHJP were randomized into 1 of 2 groups, an immediate treatment group that received MPT immediately after pretreatment testing and a waitlist control group that then received MPT after a 6-week observational period. The results demonstrated that people with CHJP had improvements in function and a reduction in hip adduction motion after participating in MPT, compared to those in the waitlist group.
12 Surprisingly, there was no significant difference between groups in hip muscle strength improvements.
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Intervention
Movement-pattern training included 6 one-hour supervised sessions and performance of a home program over a 6-week period. The MPT protocol included task-specific training to optimize lower extremity movement patterns during functional tasks and patient-specific tasks, and hip muscle strengthening. Specific details of the MPT protocol, including instructions provided to the patient and criteria to progress functional tasks and strengthening exercises, are provided in our previous report. 12 Briefly, the primary goal of task-specific training was to optimize the patient's lower extremity movement pattern during functional tasks. The primary movement impairment targeted was excessive hip adduction motion. A physical therapist provided instruction in the performance of daily functional tasks and patientspecific tasks. Patient-specific tasks included those reported by the patient to be symptom provoking, such as fitness and work-related tasks. After instruction in a more optimal movement strategy, the patient practiced performance of the task. The physical therapist provided feedback until the patient was able to perform the task independently 13 and without increasing hip joint pain. The patient was then instructed to use these modifications as he or she performed tasks throughout the day.
Hip muscle strengthening included progressive resistance exercises targeting the hip abductors, external rotators, and flexors. Patients were progressed based on their performance. Once they were able to complete 2 sets of 20 repetitions independently, as determined by the physical therapist, 13 they were progressed to the next level of difficulty. To be independent in an exercise, the patient had to demonstrate proper performance of the exercise, with activation of the targeted muscle and without compensatory strategies. Muscle activation was verified by palpation where possible. The home exercise program included those exercises the patient could perform independently and without an increase in hip joint pain. The patient was instructed to perform the home exercise program 1 time per day.
At each supervised session, the physical therapist observed the patient's performance of the assigned functional tasks and strengthening exercises. If the patient performed the functional tasks independently, then the physical therapist instructed him or her in new, more challenging tasks. If the patient was not independent in performing the task, then the physical therapist provided additional instruction. Strengthening exercises were also progressed as previously described. Prior to each supervised session, the patient documented his or her adherence to the home exercise program by answering the following question: "Since your last treatment session, what percentage of your prescribed exercises did you perform?"
Posttreatment Assessment
After completion of the treatment phase, the patients returned for laboratory testing. The patient participated in the same testing procedures for questionnaire completion and kinematic and strength assessment used during pretreatment assessment. We did not repeat the MRI acquisition because we did not expect bony morphology to change during the 6-week time frame.
Variables Measured
Two PROs, the Modified Harris Hip Score (MHHS) 6 and Hip disability and Osteoarthritis Outcome Score (HOOS), 19 were used to assess pain and hip-specific physical function. The values for the MHHS and for the HOOS subscales, including pain, symptoms, activities of daily living, sport and recreation, and QoL, range from 0 to 100, with lower scores indicating lower levels of physical function. The MHHS and HOOS have high test-retest reliability 16, 18, 25 and acceptable content validity. 18, 25 Values for minimum important change (MIC) for nonsurgical management are not available; however, Kemp et al 18 established MIC values in people with CHJP who have undergone arthroscopic surgery: MHHS, 8; and the HOOS subscales of pain, 9; symptoms, 9; activities of daily living, 6; sport and recreation, 10; and QoL, 11.
Kinematic data for a single-leg squat were captured using an 8-camera 3-D motion-capture system (Vicon; Oxford Metrics, Oxford, UK). Retroreflective markers were placed on anatomical landmarks of the pelvis and lower extremities. After a static calibration trial, the patient was instructed in the performance of the single-leg squat and allowed to practice the motion prior to testing. Three trials of the single-leg squat were then collected. Visual3D software (C-Motion, Inc, Germantown, MD) was used to build segmental models of the pelvis and lower limb and to calculate joint kinematics. The kinematic variable, determined a priori, was hip adduction motion, represented by the hip adduction angle at peak hip flexion. Using our described methods, we assessed test-retest reliability of peak hip adduction angle during the singleleg squat for a sample of 7 asymptomatic individuals, and obtained an intraclass correlation coefficient (ICC 3,3 ) 27 of 0.72 and a standard error of measurement (SEM) of 1.69°. 12 Hip abductor strength was tested in sidelying, with the hip in 15° of abduction.
14 A break test was performed using a microFET3 handheld dynamometer (Hoggan Scientific, LLC, Salt Lake City, UT). Three trials testing maximal effort were averaged. Torque was then calculated by multiplying the force by the moment arm (distance between the hip and application of the dynamometer) of the external resistance. The test-retest reliability for hip abductor strength 14 was an ICC 3,3 27 of 0.94 and SEM of 0.47.
Femoral head sphericity, an indicator of cam femoroacetabular impingement, was assessed using MRI. 11 Using a 3-D gradient-echo pelvic MRI sequence, radially reformatted imaging was performed at 30° increments along the femoral neck axis to obtain alpha angle measurements at the 3, 2, 1, and 12 o'clock positions. 20 The maximum value of the 4 measured angles was used for analysis. Interrater reliability for our measures of alpha angle 11 was an ICC 2,1 27 of 0.78 and SEM of 2.6°.
Data Analysis
Patient demographics for patients who did and did not provide posttreatment data were compared using unpaired t tests for age and BMI, Wilcoxon 2-sample tests for ordinal variables, and Fisher exact tests for categorical variables. Change was calculated by subtracting pretreatment from posttreatment values. Paired t tests were used to assess change between visits in MHHS, HOOS subscale scores, hip adduction motion, and hip abductor strength. Spearman correlation coefficients were used to assess the relationship between change in PROs and change in hip adduction motion, change in hip abductor strength, and pretreatment alpha angle, age, and BMI. A secondary analysis, calculating separate Spearman correlations for each group, was performed to determine the relationship between hip adduction motion reduction and scores on the PROs for those patients who reduced their hip adduction motion compared to those who did not. Unpaired t tests were used to assess differences among variables that may be related to treatment response between those who did and did not reduce hip adduction motion. These variables included baseline hip adduction motion, baseline abductor strength, and adherence to the home exercise program. We considered P values of less than .05 to be statistically significant.
RESULTS
T
hirty-five patients were enrolled and randomized in the initial phase. 12 Seven patients, 2 in the immediate group and 5 in the wait-list group, did not participate in treatment or posttesting, yielding 28 participants in the final analysis. There were no differences in demographics (TABLE 1) , pain reports, or PROs between those who participated in treatment and those who did not. After treatment, there was significant improvement in all PROs, hip adduction motion, and hip abductor strength compared to pretreatment values (TABLE 2) .
Greater reduction in hip adduction motion after treatment (r = -0.67, P<.01) correlated with greater improvement in MHHS (FIGURE 2, TABLE 3) . A lower BMI (r = -0.38, P = .049) was also associated with greater improvement in MHHS. No significant association was noted between change in hip adduction motion and change in HOOS subscales when assessed for all patients. Alpha angle, age, and change in hip abductor strength were not associated with change in scores on PROs (TABLE 3) .
Subgroup analyses demonstrated that for those patients who had reduced hip adduction motion after treatment (n = 18), the amount of hip adduction motion reduction was associated with improvement in scores on the HOOS subscales of pain (r = -0.50, P = .04),
[ research report ] symptoms (r = -0.48, P = .04), sport and recreation (r = -0.47, P = .05), and QoL (r = -0.59, P = .01) (TABLE 3). TABLE 4 provides pretreatment and posttreatment outcomes for each subgroup, and TABLE 5 displays the between-group comparisons among factors related to treatment response. Mean ± SD baseline hip adduction motion was greater among those who were able to reduce their hip adduction compared to those who were not (21.9° ± 7.0° versus 16.8° ± 3.2°, P = .02). Self-report treatment adherence was higher among those who reduced their hip adduction motion, but this was not significant. There were no between-group differences in baseline hip abductor strength.
DISCUSSION
P
articipation in MPT resulted in significant improvements in pain and function for individuals with CHJP. However, not all patients improved, with the patient's ability to reduce hip adduction motion after MPT being strongly associated with greater improvement. This suggests that normalizing this movement pattern may be an important component to rehabilitation. Surprisingly, improvements in hip abductor strength after treatment and femoral head sphericity were not associated with improvements in pain or function. Our results suggest that MPT may be an appropriate approach to nonoperative management for people with CHJP and that the effectiveness may be associated with the patient's potential to reduce hip adduction during functional tasks.
To our knowledge, this is the first study to investigate the relationship among mechanical factors and postrehabilitation improvement among people with CHJP. Our current sample is too small to fully assess the relationship among all pretreatment and posttreatment factors and outcomes; therefore, we focused our analysis on those mechanical factors for which we had a priori hypotheses. As expected, we found that a greater reduction in hip adduction motion was associated with a greater improvement in hip-specific function.
Rehabilitation for CHJP has previously focused primarily on strengthening or flexibility exercises targeting muscle weakness or extensibility deficits. 8, 9, 17 Although patients in our study demonstrated muscle weakness, 14 muscle strength was not associated with improvements in pain and function. Because of these relationships, we believe that improvements in pain and function primarily were due to the training component of MPT, which incorporated decreasing excessive hip adduction angle into taskspecific activities, rather than to the hipstrengthening exercises.
The goal of task-specific training is to optimize lower extremity biomechanics during daily tasks, such as walking and stair ambulation, and patient-specific tasks, such as fitness and work-related activities. Impaired movement patterns, when present, are often observed across multiple tasks. 21, 29 Based on the theory that repeated performance of an impaired movement pattern may lead to altered hip joint stresses and subsequent pain, we believe it is important to address all daily and patient-specific tasks during treatment, particularly those tasks reported to produce or increase hip symptoms. During pretreatment assessment, each patient identified specific tasks that were symptom provoking. These tasks .58 ¶ were prioritized during treatment, and training was provided to optimize the patient's movement strategy while performing these tasks. Patients were then encouraged to practice these optimal movement strategies as they performed their tasks throughout the day, resulting in frequent practice. Despite the lack of association between change in hip abductor strength and improvement in pain and function, we cannot rule out that performing hip-strengthening exercises might not have contributed to the improved movement pattern. In this study, 8 participants did not demonstrate a reduction in hip adduction motion and, interestingly, reported no improvement in the MHHS.
Understanding the factors associated with the ability to reduce hip adduction motion may assist in determining who may best benefit from the MPT approach. Based on our secondary analysis, comparing those who reduced hip adduction motion and those who did not (TABLE 5) , a potential factor of interest may be the patient's pretreatment value of hip adduction motion. Those with lower values of hip adduction at the pretreatment visit would have less ability to reduce hip adduction motion, [ research report ]
and, therefore, reducing hip adduction motion may not be the ideal treatment target for this subgroup. Accordingly, we determined that hip adduction motion at pretreatment differed between those who reduced their hip adduction motion after treatment and those who did not (mean ± SD, 21.9° ± 7.0° versus 16.8° ± 3.2°; P = .02). Based on our data, however, we are unable to recommend a specific value of hip adduction motion that may predict a patient's posttreatment outcomes. Given that the hip abductors are the primary muscles that control hip adduction during weight-bearing tasks, one would expect that stronger hip abductor muscles would play a role in the ability to reduce hip adduction motion and thus improve pain and function; however, this does not seem to be supported by our data (TABLES 3 and 5). Though their strength improved after treatment, the patients in our study demonstrated continued weakness compared to an asymptomatic control group.
14 Therefore, our results should be interpreted with some caution, given the relatively small changes in strength that took place from pretreatment to posttreatment and the relative remaining hip muscle weakness, which suggests the need for a more optimal volume or duration of the strength training program. Other factors that may contribute to the ability to reduce hip adduction motion may need to be considered, for example, the timing of muscle activation during functional tasks, which would not be represented in our strength measures. Finally, the patient's adherence to the home exercise 
Limitations
Our findings should be considered in light of several limitations. We are unable to state whether the reported change in hip adduction motion or score on the MHHS after treatment is clinically meaningful. To our knowledge, the MIC for hip adduction motion has yet to be determined. The MIC for the MHHS is based on a sample that has undergone arthroscopic surgery, and therefore may not be directly applicable to nonoperative treatment. Nevertheless, the strong association noted between hip adduction motion reduction and improvement in function supports the use of rehabilitation to target impaired movement patterns. Our sample was small and included a large majority of women, which limits the generalizability of our results. The patients with CHJP enrolled in this study represented a heterogeneous population, in that some patients had bony abnormalities and others did not. Bony morphology did not appear to be associated with treatment outcomes in our sample; however, a larger study would be needed to definitively determine the effect of bony abnormalities on treatment prognosis. We do not know the optimal dosage of MPT. It is possible that a longer duration of treatment may result in greater improvements. Finally, we are unable to comment on the individual contributions of task-specific training or muscle strengthening.
CONCLUSION
P
articipation in MPT to reduce hip adduction motion resulted in significant improvements in pain and function among patients with CHJP. Our study suggests that MPT may be an appropriate approach for people with CHJP, including those with femoroacetabular impingement. A better understanding of the factors that contribute to treatment outcomes will improve our ability to match patients to appropriate treatment strategies. t
KEY POINTS
FINDINGS: Participation in movementpattern training to reduce hip adduction motion resulted in significant improvements in pain and function among patients with chronic hip joint pain (CHJP). The patient's ability to reduce hip adduction motion was associated with greater improvements. IMPLICATIONS: Movement-pattern training, targeting hip adduction motion during daily tasks and patientspecific tasks, should be considered in the nonsurgical management of patients with CHJP. CAUTION: The sample size was small, with the vast majority of patients being women, thus limiting the generalizability of the results.
